A detailed history of Msh Capital Advisors LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Msh Capital Advisors LLC holds 6,478 shares of MRK stock, worth $537,738. This represents 0.2% of its overall portfolio holdings.

Number of Shares
6,478
Previous 6,316 2.56%
Holding current value
$537,738
Previous $576 Million 11.93%
% of portfolio
0.2%
Previous 0.27%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$96.31 - $114.76 $15,602 - $18,591
162 Added 2.56%
6,478 $644 Million
Q3 2024

Feb 13, 2025

SELL
$111.15 - $128.97 $13,449 - $15,605
-121 Reduced 1.85%
6,419 $729 Million
Q2 2024

Feb 13, 2025

BUY
$123.8 - $132.96 $5,447 - $5,850
44 Added 0.68%
6,540 $810 Million
Q1 2024

Feb 13, 2025

SELL
$113.24 - $131.95 $6,341 - $7,389
-56 Reduced 0.85%
6,496 $857 Million
Q4 2023

Feb 13, 2025

SELL
$100.18 - $109.02 $163,994 - $178,465
-1,637 Reduced 19.99%
6,552 $714 Million
Q3 2023

Feb 13, 2025

BUY
$102.95 - $114.33 $64,240 - $71,341
624 Added 8.25%
8,189 $843 Million
Q2 2023

Feb 13, 2025

BUY
$108.61 - $118.38 $7,602 - $8,286
70 Added 0.93%
7,565 $873 Million
Q1 2023

Feb 13, 2025

BUY
$102.94 - $114.86 $3,499 - $3,905
34 Added 0.46%
7,495 $797 Million
Q4 2022

Feb 13, 2025

BUY
$87.44 - $112.11 $100,818 - $129,262
1,153 Added 18.28%
7,461 $828 Million
Q3 2022

Feb 13, 2025

SELL
$84.53 - $94.96 $14,370 - $16,143
-170 Reduced 2.62%
6,308 $543 Million
Q2 2022

Feb 13, 2025

SELL
$83.49 - $94.64 $2,588 - $2,933
-31 Reduced 0.49%
6,316 $576 Million
Q1 2022

Feb 13, 2025

BUY
$73.51 - $82.4 $21,611 - $24,225
294 Added 4.86%
6,347 $521 Million
Q4 2021

Feb 13, 2025

BUY
$72.28 - $90.54 $437,510 - $548,038
6,053 New
6,053 $464 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $210B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Msh Capital Advisors LLC Portfolio

Follow Msh Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Msh Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Msh Capital Advisors LLC with notifications on news.